Study: Halegoua-DeMarzio 2023, American Journal of Medicine
Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]
Citation
Halegoua-DeMarzio D, Navarro V, Ahmad J, Avula B et al (2023). American Journal of Medicine. PubMed id 36252717.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Turmeric and curcumin supplements Tier B moderate
B Ten people in the US Drug-Induced Liver Injury Network with turmeric-associated liver injury (eight women; nine White; median age 56) (n=10)
Case series with chemical analysis of products and HLA genetic typing.
Five were hospitalised and one died of acute liver failure. Injury began 1 to 4 months after starting, mostly hepatocellular, and turmeric was confirmed in all seven products tested (three also contained black pepper extract). Seven carried HLA-B*35:01 (allele frequency 0.45 against 0.06 to 0.07 in controls). The authors say turmeric liver injury appears to be increasing.
As recorded in this card: Halegoua-DeMarzio D, Navarro V, Ahmad J, Avula B et al (2023), American Journal of Medicine, [primary]
Note: A small case series, mostly White participants, so it says nothing about how common the HLA type is in other populations. HLA-B*35:01 is the measured variable.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.